HIVE Digital Technologies Ltd. (TSXV: HIVE) Makes TSXV Top Traders List On Bitcoin's Momentum

( MENAFN - Investor Ideas) Investorideas, a go-to platform for big investing ideas, including bitcoin and crypto Stocks reports on trading for HIVE Digital Technologies Ltd. (TSXV: HIVE) (NASDAQ: HIVE) (FSE: YO0) a pioneer in green energy-powered blockchain infrastructure. HIVE Digital Technologies Ltd is currently trading at $6.

29, up 0.62, gaining 10.93% on the TSX Venture with volume of over 1.



7 Million shares as of this report. HIVE is trading at $4.5450, up 0.

4750, gaining 11.67% on the nasdaq on volume of over 6.3 Million shares.

The stock had a day's high of $6.30. Bitcoin USD (BTC-USD) is trading at $76,547.

32, up 690.38 and is still trending bullish for avid crypto traders. HIVE Digital Technologies Ltd.

went public in 2017 as the first cryptocurrency mining company listed for trading on the TSX Venture Exchange with a focus on sustainable green energy. Research more bitcoin and crypto stocks with Investorideas free stock directory About Investorideas - Big Investing Ideas Investorideas is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all.

Our original branded content includes podcasts such as Exploring Mining, Cleantech, Crypto Corner, Cannabis News, and the AI Eye. We also create free investor stock directories for sectors including mining, crypto, renewable energy, gaming, biotech, tech, sports and more. Public companies within the sectors we cover can use our news publishing and content creation services to help tell their story to interested investors.

Paid content is always disclosed. MENAFN07112024000142011025ID1108864414 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article.

If you have any complaints or copyright issues related to this article, kindly contact the provider above..